✦ LIBER ✦

A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma

✍ Scribed by Frederick Locke; Joseph I. Clark; Thomas F. Gajewski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II trial of docetaxel and oxal

✍ Kyoung Ha Kim; Young Suk Park; Myung Hee Chang; Hyo Song Kim; Hyun Jung Jun; Jie 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 274 KB

Phase I study of 3-weekly docetaxel, cap

✍ Sun Jin Sym; Min-Hee Ryu; Hye Jin Kang; Sung Sook Lee; Heung-Moon Chang; Jae Lyu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 328 KB

A phase II study of irinotecan and docet

✍ Sun Jin Sym; Heung Moon Chang; Hye Jin Kang; Sung Sook Lee; Min-Hee Ryu; Jae-Lyu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 336 KB

A phase II study of extended dose temozo

✍ Damian A. Laber; Roseline I. Okeke; Carlos Arce-Lara; Beverly S. Taft; Cassandra 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 255 KB

Phase II study of weekly docetaxel and f

✍ Eun Mi Lee; Sun Young Rha; Jeeyun Lee; Kyong Hwa Park; Jin-Hee Ahn 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 224 KB

A phase II study of the effectiveness of

✍ C. G. Alexopoulos; G. Rigatos; A. P. Efremidis; A. Papacharalambous; A. Alexopou 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 83 KB